Pretreatment of human adipose derived mesenchymal stem cells with PPAR-γ agonist improved effects of regeneration in elastase induced emphysema mouse model

Ryeon-Jin Cho (Seoul, Republic of Korea), Ryeon Jin Cho, You-Sun Kim, Ji-Young Kim, Seiwon Lee, Sang-Do Lee, Jin Won Huh, Yeon-Mok Oh

Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Session: Cellular and molecular mechanisms of COPD and emphysema
Session type: Poster Discussion
Number: 5060
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Ryeon-Jin Cho (Seoul, Republic of Korea), Ryeon Jin Cho, You-Sun Kim, Ji-Young Kim, Seiwon Lee, Sang-Do Lee, Jin Won Huh, Yeon-Mok Oh. Pretreatment of human adipose derived mesenchymal stem cells with PPAR-γ agonist improved effects of regeneration in elastase induced emphysema mouse model. Eur Respir J 2015; 46: Suppl. 59, 5060

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of low level laser (LLL) and mesenchymal stem cells (htMSCs) therapies on cigarette-induced lung inflammation in mice
Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease
Year: 2013

Exogenous administration of bone marrow-derived stem cells in experimental COPD
Source: Annual Congress 2013 –Cutting edge: drug delivery to the airways
Year: 2013

Therapeutic effects of human perivascular stem cells in an emphysema mouse model
Source: International Congress 2017 – From the bench: therapeutic approaches in COPD and emphysema
Year: 2017

Adipose derived stem cells ameliorate airway inflammation in mouse models of asthma
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015


Both intranasal and intraperitoneal administration of human tubal mesenchymal stem cells (htMSC) ameliorates experimental COPD model
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014

Characterization of human mesenchymal stem cells phenotype and secretome in a in vitro model of acute lung injury inflammation
Source: Annual Congress 2011 - Lung cell injury and repair
Year: 2011

Immunotherapeutic strategy with mesenchymal stem cells modulating inflammation in an experimental model of COPD.
Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD
Year: 2020

Different effects of mesenchymal stem cells on elastase-induced pulmonary emphysema and macrophages activity in rats
Source: Annual Congress 2011 - Recent developments in COPD
Year: 2011


Synergistic effect of human tubal mesenchymal stem cell (htMSCs) and low level laser (LLL) therapy significantly reduces experimental COPD in mice
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014

The effects of mesechymal cells isolated from abdominal adipose tissue on rat model of emphysema
Source: International Congress 2014 – Mechanisms of COPD: proteases and a whole lot more
Year: 2014

Mesenchymal stem cells from adipose tissue reduce bleomycin-induced lung remodeling in late stage
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013

LSC Abstract – Network analysis of induced pluripotent stem cells secretome reveales its anti fibrotic action in rat lung injury model
Source: International Congress 2016 – New therapies and therapeutic targets
Year: 2016


Suppression of allergic airway inflammation in a mouse model of asthma by exogenous mesenchymal stem cells
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010

Secreted mediators from induced pluripotent stem cells (iPSc) attenuate fibrosis in bleomycin injured rat lung
Source: Annual Congress 2012 - Stem cells and progenitors in injury and repair
Year: 2012

Effect of mast cells degranulation blockade on the inflammatory response outcome in the COPD model
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016


Rescue of murine silica-induced lung injury and fibrosis by human embryonic stem cells
Source: Eur Respir J 2012; 39: 446-457
Year: 2012



PBI-compound, a novel first-in-class anti-fibrotic compound, inhibits CTGF and collagen production in murine and human fibroblasts, and reduces lung fibrosis in the bleomycin-induced lung fibrosis model
Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013?
Year: 2013


Effects of autologous mesenchymal stromal cell treatment for severe emphysema on lung tissue: A clinical trial
Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease
Year: 2015


In vivo chracterization of bone marrow derived progenitor cells in airway remodeling in murine asthma model
Source: Annual Congress 2007 - Mouse models of allergic airway inflammation
Year: 2007